Benzinga | Feb 16, 2021 05:34PM EST

Sonoma Pharmaceuticals Q3 EPS $(0.32) Up From $(0.72) YoY, Sales $4.90M Up From $4.68M YoY

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.32) per share. This is a 55.56 percent increase over losses of $(0.72) per share from the same period last year. The company reported $4.90 million in sales this quarter. This is a 4.75 percent increase over sales of $4.68 million the same period last year.